CONSIDERATIONS TO KNOW ABOUT SEMAGLUTIDE 5 MG VIALS

The trial realized both of those its Most important endpoints, with semaglutide two.four mg demonstrating statistically important and outstanding advancements in liver fibrosis with no worsening of steatohepatitis, along with resolution of steatohepatitis without any worsening of liver fibrosis in those with MASH when compared with placebo.1I hold